# Marc C. Hochberg

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/marc-c-hochberg/

## Facts

| Field | Value |
| --- | --- |
| Citations | 92,513 |
| Field | Osteoarthritis Treatment and Mechanisms |
| h-index | 129 |
| i10-index | 472 |
| Last Known Institution | University of Maryland, Baltimore |
| OpenAlex ID | https://openalex.org/A5026165132 |
| ORCID iD | https://orcid.org/0000-0001-7705-5593 |
| Works | 732 |

## Researcher papers

- [Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II](https://scholariq.org/papers/estimates-of-the-prevalence-of-arthritis-and-other-rheumatic-conditions-in-the/)
- [Derivation of the sledai. A disease activity index for lupus patients](https://scholariq.org/papers/derivation-of-the-sledai-a-disease-activity-index-for-lupus-patients/)
- [Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis](https://scholariq.org/papers/comparison-of-upper-gastrointestinal-toxicity-of-rofecoxib-and-naproxen-in/)
- [American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee](https://scholariq.org/papers/american-college-of-rheumatology-2012-recommendations-for-the-use-of/)
- [OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines](https://scholariq.org/papers/oarsi-recommendations-for-the-management-of-hip-and-knee-osteoarthritis-part-ii/)
- [Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States](https://scholariq.org/papers/estimates-of-the-prevalence-of-arthritis-and-selected-musculoskeletal-disorders/)
- [Prevalence of Hip Symptoms and Radiographic and Symptomatic Hip Osteoarthritis in African Americans and Caucasians: The Johnston County Osteoarthritis Project](https://scholariq.org/papers/prevalence-of-hip-symptoms-and-radiographic-and-symptomatic-hip-osteoarthritis/)
- [Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis](https://scholariq.org/papers/tumour-necrosis-factor-antagonist-use-and-associated-risk-reduction-of/)
- [Loci associated with ischaemic stroke and its subtypes (SiGN): a genome-wide association study](https://scholariq.org/papers/loci-associated-with-ischaemic-stroke-and-its-subtypes-sign-a-genome-wide/)
- [Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria.](https://scholariq.org/papers/outcome-variables-for-osteoarthritis-clinical-trials-the-omeract-oarsi-set-of/)

## Researcher topics

- [Osteoarthritis Treatment and Mechanisms](https://scholariq.org/topics/osteoarthritis-treatment-and-mechanisms/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Bone health and osteoporosis research](https://scholariq.org/topics/bone-health-and-osteoporosis-research/)
- [Total Knee Arthroplasty Outcomes](https://scholariq.org/topics/total-knee-arthroplasty-outcomes-2/)
- [Inflammatory mediators and NSAID effects](https://scholariq.org/topics/inflammatory-mediators-and-nsaid-effects/)

## Researcher university

- [University of Maryland, Baltimore](https://scholariq.org/institutions/university-of-maryland-baltimore/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.